- Home
- MCVT vs QNTM Comparison
MCVT vs QNTM Comparison
Compare MCVT & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCVT
- QNTM
- Stock Information
- Founded
- MCVT 2007
- QNTM 1998
- Country
- MCVT United States
- QNTM Canada
- Employees
- MCVT N/A
- QNTM N/A
- Industry
- MCVT Finance Companies
- QNTM
- Sector
- MCVT Finance
- QNTM
- Exchange
- MCVT Nasdaq
- QNTM NYSE
- Market Cap
- MCVT 9.3M
- QNTM 8.7M
- IPO Year
- MCVT N/A
- QNTM N/A
- Fundamental
- Price
- MCVT $1.45
- QNTM $7.07
- Analyst Decision
- MCVT
- QNTM
- Analyst Count
- MCVT 0
- QNTM 0
- Target Price
- MCVT N/A
- QNTM N/A
- AVG Volume (30 Days)
- MCVT 30.1K
- QNTM 953.2K
- Earning Date
- MCVT 05-15-2025
- QNTM 05-13-2025
- Dividend Yield
- MCVT N/A
- QNTM N/A
- EPS Growth
- MCVT N/A
- QNTM N/A
- EPS
- MCVT 0.18
- QNTM N/A
- Revenue
- MCVT $3,301,119.00
- QNTM N/A
- Revenue This Year
- MCVT N/A
- QNTM N/A
- Revenue Next Year
- MCVT N/A
- QNTM N/A
- P/E Ratio
- MCVT $8.22
- QNTM N/A
- Revenue Growth
- MCVT 0.07
- QNTM N/A
- 52 Week Low
- MCVT $1.13
- QNTM $2.70
- 52 Week High
- MCVT $3.88
- QNTM $33.80
- Technical
- Relative Strength Index (RSI)
- MCVT 39.70
- QNTM 53.65
- Support Level
- MCVT $1.36
- QNTM $5.91
- Resistance Level
- MCVT $1.51
- QNTM $7.15
- Average True Range (ATR)
- MCVT 0.12
- QNTM 0.70
- MACD
- MCVT 0.02
- QNTM -0.05
- Stochastic Oscillator
- MCVT 55.17
- QNTM 59.79
About MCVT Mill City Ventures III Ltd.
Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that the group provides are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.